Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 823829, 9 pages
http://dx.doi.org/10.1155/2015/823829
Research Article

In Vitro Inhibitory and Cytotoxic Activity of MFM 501, a Novel Codonopsinine Derivative, against Methicillin-Resistant Staphylococcus aureus Clinical Isolates

1Antimicrobial Laboratory, Anti-Infective Branch, Bioactivity Programme, Natural Products Division, Forest Research Institute Malaysia (FRIM), 52109 Kepong, Selangor, Malaysia
2Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor, Malaysia
3Biotherapeutic Branch, Bioactivity Programme, Natural Products Division, Forest Research Institute Malaysia (FRIM), 52109 Kepong, Selangor, Malaysia
4Organic Synthesis Laboratory, Institute of Science, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor, Malaysia

Received 18 July 2014; Revised 4 November 2014; Accepted 13 November 2014

Academic Editor: Frederick D. Quinn

Copyright © 2015 Saiful Azmi Johari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. R. Sameerah, “Pattern of antibiotic usage in MOH hospitals,” in Proceedings of the New Strategies in Combating Anti-Infectives Resistance Seminar, Keynote, Melaka, Malaysia, October 2009.
  2. A. Lailatul, “Introduction: antibiotic resistance in Malaysia,” in Keynote Presentation at the New Strategies in Combating Anti- Infectives Resistance Seminar, Melaka, Malaysia, October 2009.
  3. A. J. Hughes, N. Ariffin, T. L. Huat et al., “Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia,” Infection Control and Hospital Epidemiology, vol. 26, no. 1, pp. 100–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. R. Ramli, H.-M. Neoh, M. N. Aziz, and S. Hussin, “Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling,” Infectious Disease Reports, vol. 4, no. 1, pp. 71–72, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ahmad, L. N. Ling, M. K. A. Ghani, and S. Nawi, “The presence of heterogeneous vancomycin-intermediate Staphylococcus aureus (heteroVISA) in a major Malaysian hospital,” Medical Journal of Malaysia, vol. 67, no. 3, pp. 269–273, 2012. View at Google Scholar · View at Scopus
  6. M. N. Shamsudin, Z. Sekawi, A. van Belkum, and V. Neela, “First community-acquired meticillin-resistant Staphylococcus aureus in Malaysia,” Journal of Medical Microbiology, vol. 57, no. 9, pp. 1180–1181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ahmad, I. N. Ruzan, M. K. A. Ghani et al., “Characteristics of community- and hospital-acquired meticillin-resistant Staphylococcus aureus strains carrying SCC mec type IV isolated in Malaysia,” Journal of Medical Microbiology, vol. 58, no. 9, pp. 1213–1218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Otto, “Community-associated MRSA: a dangerous epidemic,” Future Microbiology, vol. 2, no. 5, pp. 457–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gibbons, “Anti-staphylococcal plant natural products,” Natural Product Reports, vol. 21, no. 2, pp. 263–277, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Chopra, “Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures,” Expert Review of Anti-Infective Therapy, vol. 1, no. 1, pp. 45–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Asano, R. J. Nash, R. J. Molyneux, and G. W. J. Fleet, “Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application,” Tetrahedron Asymmetry, vol. 11, no. 8, pp. 1645–1680, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Steglich, “Slime molds (myxomycetes) as a source of new biological active metabolites,” Pure and Applied Chemistry, vol. 61, no. 3, pp. 281–288, 1989. View at Google Scholar
  13. S. F. Matkhalikova, V. M. Malikov, and S. Y. Yunusov, “The structure of codonopsinine,” Chemistry of Natural Compounds, vol. 5, no. 6, p. 530, 1969. View at Publisher · View at Google Scholar · View at Scopus
  14. S. F. Aripova, “Alkaloid content of Codonopsis clematidea,” Chemistry of Natural Compounds, vol. 32, no. 4, pp. 564–565, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. D. E. Zaurov, I. V. Belolipov, A. G. Kurmukov et al., “The medicinal plants of Uzbekistan and Kyrgyzstan,” in Medicinal Plants of Central Asia: Uzbekistan and Kyrgyzstan, S. W. Eisenman, D. E. Zaurov, and L. Struwe, Eds., pp. 74–75, Springer, New York, NY, USA, 2012. View at Google Scholar
  16. S. Ishida, M. Okasaka, F. Ramos et al., “New alkaloid from the aerial parts of Codonopsis clematidea,” Journal of Natural Medicines, vol. 62, no. 2, pp. 236–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Rakhimov, E. S. Salimova, and R. P. Zakirova, “Polysaccharides of plant tissue culture. III. Polysaccharides of Codonopsis clematidea callus culture,” Chemistry of Natural Compounds, vol. 39, no. 1, pp. 46–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Reddy and B. V. Rao, “A short, efficient, and stereoselective total synthesis of a pyrrolidine alkaloid: ( )-codonopsinine,” The Journal of Organic Chemistry, vol. 72, no. 6, pp. 2224–2227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Chandrasekhar, V. Jagadeshwar, and S. J. Prakash, “Total synthesis of the alkaloid (-)-codonopsinine from L-xylose,” Tetrahedron Letters, vol. 46, no. 17, pp. 3127–3129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Toyao, O. Tamura, H. Takagi, and H. Ishibashi, “A concise synthesis of (-)-codonopsinine and an approach to synthesis of (+)-hyacinthacines 1 and A2 from a polyhydroxylated cyclic nitrone,” Synlett, vol. 1, no. 1, pp. 35–38, 2003. View at Google Scholar
  21. H. Iida, N. Yamazaki, C. Kibayashi, and H. Nagase, “Stereochemical revision and absolute configuration of codonopsinine,” Tetrahedron Letters, vol. 27, no. 44, pp. 5393–5396, 1986. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Mohammat, Z. Shaameri, and A. S. Hamzah, “Synthesis of 2,3-dioxo-5-(substituted)arylpyrroles and their 2-oxo-5-aryl-3-hydrazone pyrrolidine derivatives,” Molecules, vol. 14, no. 1, pp. 250–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Mohammat, N. Najim, N. S. Mansor et al., “Synthesis and bioactivity of some 2-oxo-5-aryl-3-hydrazone and 2-oxo-5-aryl-4-hydrazone pyrrolidine derivatives,” Arkivoc, vol. 2011, no. 9, pp. 429–438, 2011. View at Google Scholar · View at Scopus
  24. A. J. Saiful, M. Mastura, S. Zarizal, M. I. Mazurah, M. Shuhaimi, and A. M. Ali, “Detection of methicillin-resistant Staphylococcus aureus using mecA/nuc genes and antibiotic susceptibility profile of Malaysian clinical isolates,” World Journal of Microbiology and Biotechnology, vol. 22, no. 12, pp. 1289–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Suhaili, S. A. Johari, M. H. Sajili et al., “In silico PCR verification and simplex real-time PCR detection of methicillin-resistant Staphylococcus aureus (MRSA) from east coast Malaysian clinical isolates,” Walailak Journal of Science and Technology, vol. 10, no. 3, pp. 237–246, 2013. View at Google Scholar · View at Scopus
  26. A. J. Saiful, M. Mastura, S. Zarizal, M. I. Mazurah, M. Shuhaimi, and A. M. Ali, “Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA),” Journal of Basic Microbiology, vol. 48, no. 4, pp. 245–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Mohtar, S. A. Johari, A. R. Li et al., “Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA),” Current Microbiology, vol. 59, no. 2, pp. 181–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover, “Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 1, pp. 135–136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. S. G. Chadwick, A. Prasad, W. L. Smith, E. Mordechai, M. E. Adelson, and S. E. Gygax, “Detection of epidemic USA300 community-associated methicillin-resistant Staphylococcus aureus strains by use of a single allele-specific PCR assay targeting a novel polymorphism of Staphylococcus aureus pbp3,” Journal of Clinical Microbiology, vol. 51, no. 8, pp. 2541–2550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Gibbons, “Phytochemicals for bacterial resistance—strengths, weaknesses and opportunities,” Planta Medica, vol. 74, no. 6, pp. 594–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. A. Pankey and L. D. Sabath, “Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections,” Clinical Infectious Diseases, vol. 38, no. 6, pp. 864–870, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. G. Bartlett, “Antibiotic selection for infections involving methicillin-resistant Staphylococcus aureus,” http://www.medscape.com/viewarticle/478151_1.
  34. M. E. Levison, “Pharmacodynamics of antimicrobial drugs,” Infectious Disease Clinics of North America, vol. 18, no. 3, pp. 451–465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. W. E. Rose, M. Fallon, J. J. M. Moran, and J. P. Vanderloo, “Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: Influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 8, pp. 4422–4427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Zarranz, A. Jaso, I. Aldana, and A. Monge, “Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives,” Bioorganic and Medicinal Chemistry, vol. 11, no. 10, pp. 2149–2156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. F.-C. Valdés, J. M. Martínez, R. S. Lizama, M. Vermeersch, P. Cos, and L. Maes, “In vitro anti-microbial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L,” Memorias do Instituto Oswaldo Cruz, vol. 103, no. 6, pp. 615–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Vicente, S. Pérez-Silanes, L. M. Lima et al., “Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides,” Bioorganic & Medicinal Chemistry, vol. 17, no. 1, pp. 385–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Moreira Osório, F. Delle Monache, L. Domeneghini Chiaradia et al., “Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 1, pp. 225–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. B. Dewal, A. S. Wani, C. Vidaillac, D. Oupický, M. J. Rybak, and S. M. Firestine, “Thieno[2,3-d]pyrimidinedione derivatives as antibacterial agents,” European Journal of Medicinal Chemistry, vol. 51, pp. 145–153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Jin and J. K. Zjawiony, “5-Alkylresorcinols from Merulius incarnatus,” Journal of Natural Products, vol. 69, no. 4, pp. 704–706, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Guo, L.-S. Feng, M.-L. Liu et al., “Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N'-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5498–5506, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C.-H. Oh and J.-H. Cho, “Synthesis and biological evaluation of 1β-methylcarbapenems having guanidino moieties,” European Journal of Medicinal Chemistry, vol. 41, no. 1, pp. 50–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. C.-H. Oh, S.-C. Lee, and J.-H. Cho, “Synthesis and biological activity of 1β-methyl-2-[5-(2-N-substituted aminoethylcarbamoyl)pyrrolidin-3-ylthio]carbapenem derivatives,” European Journal of Medicinal Chemistry, vol. 38, no. 9, pp. 841–850, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Inagaki, S. Miyauchi, R. N. Miyauchi et al., “Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents,” Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 1005–1015, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. M. E. Hensler, G. Bernstein, V. Nizet, and A. Nefzi, “Pyrrolidine bis-cyclic guanidines with antimicrobial activity against drug-resistant Gram-positive pathogens identified from a mixture-based combinatorial library,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 19, pp. 5073–5079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Y. Hong, “Discovery of gemifloxacin (Factive, LB20304a): a quinolone of new a generation,” Farmaco, vol. 56, no. 1-2, pp. 41–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Imamura, N. Ohtake, A. Shimizu et al., “Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Part 1:J-111,347 and related compounds,” Bioorganic and Medicinal Chemistry Letters, vol. 10, no. 2, pp. 109–113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Kalhora, A. Dadras, A. Mobinikhaledi, and H. Tajik, “A new method for one-pot synthesis of aryloxyphenoxypropionate herbicides using 2,4,6-trichloro-1,3,5-triazine and (n-Bu)4Ni as a homogeneous catalyst,” Journal of the Chilean Chemical Society, vol. 56, no. 4, pp. 833–836, 2011. View at Google Scholar
  50. J. Baiget, S. Llona-Minguez, S. Lang, S. P. MacKay, C. J. Suckling, and O. B. Sutcliffe, “Manganese dioxide mediated one-pot synthesis of methyl 9H-pyrido[3,4-b] indole-1-carboxylate: concise synthesis of alangiobussinine,” Beilstein Journal of Organic Chemistry, vol. 7, pp. 1407–1411, 2011. View at Publisher · View at Google Scholar · View at Scopus